Cargando…

Abdominal Fat Biopsy for the Diagnosis of Cardiac Amyloidosis

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Aimo, Alberto, Emdin, Michele, Musetti, Veronica, Pucci, Angela, Vergaro, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Viewpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311869/ https://www.ncbi.nlm.nih.gov/pubmed/34317444 http://dx.doi.org/10.1016/j.jaccas.2020.05.062

Ejemplares similares

Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient
por: Vergaro, Giuseppe, et al.
Publicado: (2021)

Tissue Characterization in Cardiac Amyloidosis
por: Musetti, Veronica, et al.
Publicado: (2022)

Amyloid Deposits and Fibrosis on Left Ventricular Endomyocardial Biopsy Correlate With Extracellular Volume in Cardiac Amyloidosis
por: Pucci, Angela, et al.
Publicado: (2021)

Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis
por: Emdin, Michele, et al.
Publicado: (2023)

Atrial amyloidosis: mechanisms and clinical manifestations
por: Vergaro, Giuseppe, et al.
Publicado: (2022)

Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta‐analysis of screening studies
por: Aimo, Alberto, et al.
Publicado: (2022)

Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance
por: Martini, Nicola, et al.
Publicado: (2020)

Valve disease in cardiac amyloidosis: an echocardiographic score
por: Aimo, Alberto, et al.
Publicado: (2023)

Cardiovascular toxicity from therapies for light chain amyloidosis
por: Morfino, Paolo, et al.
Publicado: (2023)

Biomarkers for the diagnosis and management of heart failure
por: Castiglione, Vincenzo, et al.
Publicado: (2021)

Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis
por: Morfino, Paolo, et al.
Publicado: (2022)

Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study
por: Nicol, Martin, et al.
Publicado: (2023)

Thromboembolism and bleeding in systemic amyloidosis: a review
por: Nicol, Martin, et al.
Publicado: (2021)

Biomarkers of HFpEF: Natriuretic Peptides, High-Sensitivity Troponins and Beyond
por: Morfino, Paolo, et al.
Publicado: (2022)

Risk Stratification in Transthyretin Cardiac Amyloidosis: The Added Value of Lung Spirometry
por: Banydeen, Rishika, et al.
Publicado: (2023)

Diagnosis and typing of systemic amyloidosis: The role of abdominal fat pad fine needle aspiration biopsy
por: Halloush, Ruba A, et al.
Publicado: (2010)

The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction
por: Aimo, Alberto, et al.
Publicado: (2021)

Renin profiling predicts neurohormonal response to sacubitril/valsartan
por: Vergaro, Giuseppe, et al.
Publicado: (2020)

Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis
por: Quarta, Candida Cristina, et al.
Publicado: (2017)

Value of the HFA‐PEFF and H(2)FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis
por: Tomasoni, Daniela, et al.
Publicado: (2022)

Subclinical cardiac damage in cancer patients before chemotherapy
por: Fabiani, Iacopo, et al.
Publicado: (2021)

Utility of abdominal skin plus subcutaneous fat and rectal mucosal biopsy in the diagnosis of AL amyloidosis with renal involvement
por: Li, Ting, et al.
Publicado: (2017)

Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis
por: Aimo, Alberto, et al.
Publicado: (2021)

What Is Hidden Behind Inferior Negative T Waves: Multiple Cardiac Glomangiomas
por: Castiglione, Vincenzo, et al.
Publicado: (2019)

Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy
por: Morfino, Paolo, et al.
Publicado: (2023)

Correction: Utility of abdominal skin plus subcutaneous fat and rectal mucosal biopsy in the diagnosis of AL amyloidosis with renal involvement
Publicado: (2017)

Molecular Autopsy of Sudden Cardiac Death in the Genomics Era
por: Castiglione, Vincenzo, et al.
Publicado: (2021)

Abdominal fat pad biopsies exhibit good diagnostic accuracy in patients with suspected transthyretin amyloidosis
por: Paulsson Rokke, Hedvig, et al.
Publicado: (2020)

Pathophysiological Rationale and Clinical Evidence for Neurohormonal Modulation in Heart Failure with Preserved Ejection Fraction
por: Castiglione, Vincenzo, et al.
Publicado: (2023)

Prognostic Value of sST2 in Heart Failure
por: Sciatti, Edoardo, et al.
Publicado: (2023)

Longitudinal strain in the management of cardiac AL amyloidosis: do we need it?
por: Rapezzi, Claudio, et al.
Publicado: (2021)

Prognostic Benefit of New Drugs for HFrEF: A Systematic Review and Network Meta-Analysis
por: Pagnesi, Matteo, et al.
Publicado: (2022)

The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism
por: Sanguinetti, Chiara, et al.
Publicado: (2022)

Cardiac Amyloidosis Diagnosed by Endomyocardial Biopsy
por: Kim, Myung A, et al.
Publicado: (1988)

Endomyocardial Biopsy for the Diagnosis of Transthyretin Cardiac Amyloidosis in the Era of Multimodality Imaging
por: Sunayama, Tsutomu, et al.
Publicado: (2021)

STRATAFIX for Abdominal Wall Repair following Abdominal Flap Harvest
por: Yasuda, Shoko, et al.
Publicado: (2017)

Current and emerging drug targets in heart failure treatment
por: Ghionzoli, Nicolò, et al.
Publicado: (2021)

Integrated Imaging to Investigate Low-Flow Alarms of Left Ventricular Assist Devices
por: Aimo, Alberto, et al.
Publicado: (2020)

Fat biopsy from a pocket of cardiac implantable electronic device: An alternative diagnostic option for cardiac amyloidosis
por: Takano, Ryo, et al.
Publicado: (2022)

The Fat of Bichat as Additional Source for Head and Face Fat Transfer Procedures
por: Rey, Roberto Miguel
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rs2j5q97tln4ps25aeuqf7dvlc